✦ LIBER ✦

Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease

✍ Scribed by Giovanni Targher; Christopher P. Day

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 369 KB
Volume: 53
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.23901

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Liver enzymes, nonalcoholic fatty liver

Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: A narrative review and clinical perspective of prospective data

✍ Nazim Ghouri; David Preiss; Naveed Sattar 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB

Nonalcoholic fatty liver disease and liv

Nonalcoholic fatty liver disease and liver transplantation

✍ Paul Angulo 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB

Nonalcoholic fatty liver disease affects a substantial proportion of the general population worldwide. This high prevalence of nonalcoholic fatty liver disease has important consequences in the donor selection process for liver transplantation, and in the posttransplant period given the high recurre

Nonalcoholic fatty liver disease after l

Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease

✍ Kanthi Yalamanchili; Sherif Saadeh; Göran B. Klintmalm; Linda W. Jennings; Gary 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 262 KB

Nonalcoholic steatohepatitis (NASH) may account for many cases of cryptogenic cirrhosis. If so, then steatosis might recur after liver transplantation. Two thousand fifty-two patients underwent primary liver transplantation for chronic liver disease between 1986 and 2004. Serial liver biopsy samples

Insulin resistance links nonalcoholic fa

Insulin resistance links nonalcoholic fatty liver to cardiovascular diseases

✍ Federico Salamone; Fabio Galvano; Giovanni Li Volti 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 296 KB 👁 2 views

We read with interest the reviews by Ghouri et al. 1 and Martinez et al. 2 Ghouri et al. analyzed the association of nonalcoholic fatty liver disease (NAFLD) with cardiovascular disease (CVD) and concluded that although a diagnosis of NAFLD should prompt diabetes screening, it is insufficient for co

Endothelial dysfunction and cardiovascul

Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease

✍ Nicola Villanova; Simona Moscatiello; Stefano Ramilli; Elisabetta Bugianesi; Don 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

Nonalcoholic fatty liver disease (NAFLD) is consistently associated with features of the metabolic syndrome, a condition carrying a high risk of cardiovascular events. We measured the vasodilatory response of the brachial artery in response to ischemia (a test of endothelial function) (FMV) as well

Valproate therapy and nonalcoholic fatty

Valproate therapy and nonalcoholic fatty liver disease

✍ Gerhard J. Luef; Markus Waldmann; Wolfgang Sturm; Anis Naser; Eugen Trinka; Iris 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 1 views

## Abstract Nonalcoholic fatty liver disease was defined recently as another symptom of insulin resistance. Continuous therapy with valproate can result in increased body weight and insulin resistance, but no data are yet available on a possible relationship between valproate and nonalcoholic fatty